The HSE wishes to establish a new national multi-supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home. The HSE is now seeking Expressions of Interest from Providers who wish to be considered by the HSE for this contract. For full details please see the Expression of Interest documentation, available to download from the etenders site (http://www.etenders.gov.ie).
Deadline
The time limit for receipt of tenders was 2018-05-28.
The procurement was published on 2018-04-26.
Contract notice (2018-04-26) Object Scope of the procurement
Title: Home medical treatment services
Reference number: HSE 9648
Short description:
The HSE wishes to establish a new national multi-supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
The HSE is now seeking Expressions of Interest from Providers who wish to be considered by the HSE for this contract.
For full details please see the Expression of Interest documentation, available to download from the etenders site (http://www.etenders.gov.ie).
The HSE wishes to establish a new national multi-supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
The HSE is now seeking Expressions of Interest from Providers who wish to be considered by the HSE for this contract.
For full details please see the Expression of Interest documentation, available to download from the etenders site (http://www.etenders.gov.ie).
Notice metadata
Original language: English ๐ฃ๏ธ
Document type: Contract notice
Nature of contract: Services
Regulation: European Union, with participation of GPA countries
Common procurement vocabulary (CPV)
Code: Home medical treatment services๐ฆ
Additional CPV: Pharmaceutical products๐ฆ Place of performance
NUTS region: รire/Ireland
๐๏ธ
Procedure
Procedure type: Restricted procedure
Type of bid: Submission for all lots
Award criteria
The most economic tender
The contract will be for 12 months with an option to extend for a further 24 months at 12 monthly intervals.
For full details, please see the Expression of Interest Documentation, available to download from the etenders website (http://www.etenders.gov.ie/).
The contract will be for 12 months with an option to extend for a further 24 months at 12 monthly intervals.
For full details, please see the Expression of Interest Documentation, available to download from the etenders website (http://www.etenders.gov.ie/).
Object Scope of the procurement
Short description:
The HSE wishes to establish a new national multi-supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
The HSE wishes to establish a new national multi-supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
The HSE is now seeking Expressions of Interest from Providers who wish to be considered by the HSE for this contract.
For full details please see the Expression of Interest documentation, available to download from the etenders site (http://www.etenders.gov.ie).
Estimated total value: 1 EUR ๐ฐ
Short description:
The HSE wishes to establish a new national multi Supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
The HSE wishes to establish a new national multi Supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
Complementary information Review body
Name: The High Court
Postal address: Four Courts
Postal town: Dublin 7
Country: Ireland ๐ฎ๐ช
Source: OJS 2018/S 082-184456 (2018-04-26)